Submitted by mphilemon@resea... on Fri, 02/19/2010 - 11:00
Outcomes of Women Who Were Premenopausal at Diagnosis in the MA17 Trial of Extended Letrozole After Five Years of Tamoxifen
Slides from a presentation at SABCS 2009 and transcribed comments from a recent interview with Rowan T Chlebowski, MD, PhD (12/30/09)
Dr Chlebowski is Professor of Medicine at the David Geffen School of Medicine at UCLA and Chief of the Division of Medical Oncology and Hematology at Harbor-UCLA Medical Center in Torrance, California.
Presentation discussed in this issue:
Goss PE et al. Outcomes of women who were premenopausal at diagnosis of early stage breast cancer in the NCIC CTG MA17 trial. San Antonio Breast Cancer Symposium 2009;Abstract 13.
Go to previous Journal Club Go to next Journal Club